Literature DB >> 11010069

Metabolic and endocrine changes in persons aging with spinal cord injury.

W A Bauman1, A M Spungen, R H Adkins, B J Kemp.   

Abstract

Persons with spinal cord injury (SCI) have secondary medical disabilities that impair their ability to function. With paralysis, dramatic deleterious changes in body composition occur acutely with further adverse changes ensuing with increasing duration of injury. Lean mass, composed of skeletal muscle and bone, is lost and adiposity is relatively increased. The body composition changes may be further exacerbated by associated reductions in anabolic hormones, testosterone, and growth hormone. Individuals with SCI also have decreased levels of activity. These body composition and activity changes are associated with insulin resistance, disorders in carbohydrate and lipid metabolism, and may be associated with premature cardiovascular disease. Although limited information is available, upper body exercise and cycle ergometry of the lower extremities by functional electrical stimulation (FES) have been reported to have a salutary effect on these body composition and metabolic sequelae of paralysis. Perhaps other innovative, externally mediated forms of active exercise of the paralyzed extremities will result in an increased functional capacity, metabolic improvement, and reduction of atherosclerotic vascular disease.

Entities:  

Mesh:

Year:  1999        PMID: 11010069     DOI: 10.1080/10400435.1999.10131993

Source DB:  PubMed          Journal:  Assist Technol        ISSN: 1040-0435


  30 in total

1.  Assessing stress in disability: developing and piloting the Disability Related Stress Scale.

Authors:  Paula C Rhode; Katherine Froehlich-Grobe; Jill R Hockemeyer; Jordan A Carlson; Jaehoon Lee
Journal:  Disabil Health J       Date:  2012-04-20       Impact factor: 2.554

2.  Prevalence of androgen deficiency in chronic spinal cord injury patients suffering from erectile dysfunction.

Authors:  M Behnaz; Z Majd; M Radfar; H Ajami; M Qorbani; A Kokab
Journal:  Spinal Cord       Date:  2017-06-20       Impact factor: 2.772

3.  Optimal scaling of weight and waist circumference to height for adiposity and cardiovascular disease risk in individuals with spinal cord injury.

Authors:  J J Cragg; H J C Rianne Ravensbergen; J F Borisoff; V E Claydon
Journal:  Spinal Cord       Date:  2014-09-30       Impact factor: 2.772

4.  Prevalence and Etiology of Hypogonadism in Young Men With Chronic Spinal Cord Injury: A Cross-Sectional Analysis From Two University-Based Rehabilitation Centers.

Authors:  Shannon D Sullivan; Mark S Nash; Eshetu Tefera; Emily Tinsley; Marc R Blackman; Suzanne Groah
Journal:  PM R       Date:  2016-11-18       Impact factor: 2.298

5.  Longitudinal changes in medical complications in adults with pediatric-onset spinal cord injury.

Authors:  Miriam Hwang; Kathy Zebracki; Kathleen M Chlan; Lawrence C Vogel
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

6.  Physiological responses to exergaming after spinal cord injury.

Authors:  Patricia Burns; Jochen Kressler; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

7.  Evidence for an exaggerated postprandial lipemia in chronic paraplegia.

Authors:  Mark S Nash; Joris DeGroot; Alberto Martinez-Arizala; Armando J Mendez
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

8.  Normative blood pressure and heart rate in pediatric spinal cord injury.

Authors:  Miriam Hwang; Kathy Zebracki; Randal R Betz; M J Mulcahey; Lawrence C Vogel
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

Review 9.  Exercise recommendations for individuals with spinal cord injury.

Authors:  Patrick L Jacobs; Mark S Nash
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Nutrient intake and body habitus after spinal cord injury: an analysis by sex and level of injury.

Authors:  Suzanne L Groah; Mark S Nash; Inger H Ljungberg; Alexander Libin; Larry F Hamm; Emily Ward; Patricia A Burns; Gwen Enfield
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.